Haematological cancer

Redefining myeloma

S Vincent Rajkumar, Giampaolo Merlini, Jesus F. San Miguel

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The current definition of multiple myeloma is outdated. The diagnosis requires evidence of overt end-organ damage, preventing initiation of early therapy when the malignancy is at its most susceptible stage. We propose an evidence-based approach using more-sensitive and highly specific biomarkers to update the definition of this disease.

Original languageEnglish (US)
Pages (from-to)494-496
Number of pages3
JournalNature Reviews Clinical Oncology
Volume9
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Secondary Prevention
Multiple Myeloma
Biomarkers
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Haematological cancer : Redefining myeloma. / Rajkumar, S Vincent; Merlini, Giampaolo; San Miguel, Jesus F.

In: Nature Reviews Clinical Oncology, Vol. 9, No. 9, 09.2012, p. 494-496.

Research output: Contribution to journalArticle

Rajkumar, S Vincent ; Merlini, Giampaolo ; San Miguel, Jesus F. / Haematological cancer : Redefining myeloma. In: Nature Reviews Clinical Oncology. 2012 ; Vol. 9, No. 9. pp. 494-496.
@article{58676ddfb5a24bc8bf0a51ad0a42cfa0,
title = "Haematological cancer: Redefining myeloma",
abstract = "The current definition of multiple myeloma is outdated. The diagnosis requires evidence of overt end-organ damage, preventing initiation of early therapy when the malignancy is at its most susceptible stage. We propose an evidence-based approach using more-sensitive and highly specific biomarkers to update the definition of this disease.",
author = "Rajkumar, {S Vincent} and Giampaolo Merlini and {San Miguel}, {Jesus F.}",
year = "2012",
month = "9",
doi = "10.1038/nrclinonc.2012.128",
language = "English (US)",
volume = "9",
pages = "494--496",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Haematological cancer

T2 - Redefining myeloma

AU - Rajkumar, S Vincent

AU - Merlini, Giampaolo

AU - San Miguel, Jesus F.

PY - 2012/9

Y1 - 2012/9

N2 - The current definition of multiple myeloma is outdated. The diagnosis requires evidence of overt end-organ damage, preventing initiation of early therapy when the malignancy is at its most susceptible stage. We propose an evidence-based approach using more-sensitive and highly specific biomarkers to update the definition of this disease.

AB - The current definition of multiple myeloma is outdated. The diagnosis requires evidence of overt end-organ damage, preventing initiation of early therapy when the malignancy is at its most susceptible stage. We propose an evidence-based approach using more-sensitive and highly specific biomarkers to update the definition of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84865698946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865698946&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2012.128

DO - 10.1038/nrclinonc.2012.128

M3 - Article

VL - 9

SP - 494

EP - 496

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 9

ER -